In Brief
Refine Search
Pharmaceutical
UK-based immunotherapy firm Centauri Therapeutics has secured a £1 million ($1.25 million) grant from PACE (Pathways to Antimicrobial Clinical Efficacy) to further develop its Alphamer technology. 25 November 2024
Biotechnology
Germany’s Evotec says it has taken notice of the statement made by Halozyme Therapeutics on November 22, stating that it has withdrawn its non-binding proposal to acquire Evotec for 11.00 euros per share in cash. 23 November 2024
Biotechnology
Colorado, USA-based OncoVerity announced the closing of a series A extension led by existing investors, argenX and RefinedScience. The value was not disclosed, but this extension follows a $30 million Series A fundraiser in March 2023. 22 November 2024
Biotechnology
Sweden-based BioArctic saw its fall 7.5% to 139.90 kronor on Friday, after its announced that its partner, Japan’s Eisa, has updated its revenue outlook for the Alzheimer’s treatment Leqembi (lecanemab) for the 2024 fiscal year (FY), which runs from April 2024 through March 2025. 11 November 2024
Biotechnology
Danish biotech Gubra announces that Germany’s Boehringer Ingelheim has decided to discontinue the development of the long-acting neuropeptide Y receptor type 2 (NPY2R) agonist BI 1820237 in obesity. 4 November 2024
Biotechnology
Japanese drugmaker Eisai has completed the rolling submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for lecanemab-irmb (US brand name Leqembi) subcutaneous autoinjector for weekly maintenance dosing after it was granted Fast Track designation by the FDA. 1 November 2024
Pharmaceutical
GSK has announced its largest US manufacturing investment to date, dedicated to producing medicines and vaccines. 25 October 2024
Pharmaceutical
Following a re-examination, the European Medicines Agency’s human health committee, CHMP confirmed its initial recommendation to refuse the granting of a conditional marketing authorization for Masitinib AB Science’s masitinib. 18 October 2024
Pharmaceutical
University Medical Center Groningen (UMCG) and SHINE Europe have secured a 10.5 million euro ($11 million) grant to advance European production of terbium isotopes for cancer treatments. 17 October 2024
Pharmaceutical
Danish dermatology focused LEO Pharma has announced the launch of Anzupgo (delgocitinib) cream in Germany for the treatment of adult patients with moderate to severe chronic hand eczema (CHE), for whom topical corticosteroids are inadequate or inappropriate. 15 October 2024
Pharmaceutical
French pharma major Sanofi revealed it has entered into negotiations with private equity firm Clayton Dubilier & Rice (CD&R) for the potential sale of a 50% controlling stake in Opella, its consumer healthcare business. 14 October 2024
Pharmaceutical
The UK’s new 2024 voluntary scheme for branded medicines pricing, access, and growth (VPAG) came into force at the beginning of January this year. 4 October 2024
Biotechnology
Sirnaomics, a firm specializing in RNAi therapeutics, has entered into a subscription agreement with biotech specialist Poon Hung Fai. 4 October 2024
Biotechnology
GigaGen has been awarded a contract by the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) within the US Department of Health and Human Services (HHS). 4 October 2024
Biotechnology
Oxford, UK-based Enara Bio today announces the closing of a $32.5 million Series B financing supported by a strong syndicate of new and existing biotech investors. 3 October 2024
Pharmaceutical
French drugmaker Mitem Pharmavhas the worldwide acquisition of Desferal (deferoxamine), a major MITM in hematology, from Swiss giant Novartis. 25 September 2024
article
The European Medicines Agency’s (EMA) Committee for Human Medicinal Products (CHMP) has elected Bruno Sepodes as its new chair. 19 September 2024
Pharmaceutical
The Austrian Academy of Sciences (OeAW) is further expanding its focus on life sciences by opening an institute for biomedical artificial intelligence (AI) based on a 150 million euros ($166.8 million) funding from the German non-profit Boehringer Ingelheim Foundation (BIS). 18 September 2024
Biotechnology
Zenas BioPharma announced the pricing of its upsized initial public offering of 13,235,294 shares of its common stock at an initial public offering price of $17.00 per share. 13 September 2024
Biotechnology
Evelo Biosciences revealed in a stock exchange filing that, in the best interests of the company and its stockholders, the business will be dissolved. 22 November 2023
Biotechnology
Two subsidiaries of Connect Biopharma are to work together with Simcere Pharmaceutical on the development of rademikibart in China, Hong Kong, Macau and Taiwan. 22 November 2023
Biotechnology
Life science investor Syncona has announced that its newly-established portfolio company has entered into an agreement to buy the remaining stake in Freeline Therapeutics. 22 November 2023
Biotechnology
Oncoteq, a company founded and seeded by Cureteq and headquartered in Zug, Switzerland, today announced its second in-licensing deal as it obtains a world-wide exclusive license to a novel compound with potential to shift the paradigm in breast cancer treatment. 22 November 2023
Biotechnology
Massachusetts, USA-based biotech funder and incubator Flagship Pioneering today unveiled Quotient Therapeutics, a new company pioneering somatic genomics. 22 November 2023
Biotechnology
Germany-based Medigene has announced an update and prioritization of its pipeline and resource allocation in support of its long-term corporate strategy. 22 November 2023
Biotechnology
It has been a challenging week for Germany's MorphoSys, with the firm’s share price falling as much as 40% in the last five days. 22 November 2023
Pharmaceutical
InDex Pharmaceuticals Pharmaceuticals plunged 60% to 0.26 kronor this morning, as it reported a failed clinical trial for its ulcerative colitis candidate cobitolimod. 22 November 2023
Pharmaceutical
Japanese drugmaker Sumitomo Pharma has received approval from China’s National Medical Products Administration (NMPA) for the use of Xenleta (lefamulin acetate) to treat adults with community-acquired pneumonia in injection and tablet formulation. 22 November 2023
Biotechnology
The chief executive of Swiss rare disease company Relief Therapeutics, Jack Weinstein, is to step down. 22 November 2023
Pharmaceutical
Complex regional pain syndrome (CRPS) is a chronic and potentially debilitating neuropathic pain condition that typically affects an extremity, such as an arm or leg.1 22 November 2023
Pharmaceutical
Signalling a strategic shift towards research, artificial intelligence (AI), blockchain, and patent laws, the Indian government has released a draft of the National Pharmaceutical Policy, inviting crucial inputs from industry stakeholders. 22 November 2023
Biosimilars
Russian pharmaceutical companies are eyeing expanding in the United Arab Emirates (UAE) by launching production of their drugs and establishing their manufacturing facilities in the local market. 22 November 2023
Biotechnology
Chinese oncology specialist BeiGene and privately-held Ensem Therapeutics have announced a deal. 21 November 2023
Biotechnology
The fate of Belgian biopharma Oxurion has been sealed. 21 November 2023
Pharmaceutical
In 1984, Congress passed and the President signed into law the Drug Price Competition and Patent Term Restoration Act, better known as the Hatch-Waxman Act. 21 November 2023
Biotechnology
A new multi-year collaboration between Swiss pharma giant Roche subsidiary Genentech and US tech firm NVIDIA aims to transform the discovery and development of new medicines by bringing together experts from each company to optimize and accelerate Genentech’s proprietary algorithms. 21 November 2023
Biotechnology
In the rush to develop effective vaccines against the novel coronavirus, several companies have sued, and counter-sued, for patent infringement, with potentially billions on the line. 21 November 2023
Pharmaceutical
Just six months after raising $150 million in an upsized series E financing, cardiometabolic specialist Carmot Therapeutics has filed for an initial public offering (IPO). 21 November 2023
Biosimilars
Indian pharmaceutical company Jodas Expoim is experiencing serious problems with the construction of its first enterprise in the Russian Federation. 21 November 2023
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze